|
GB771147A
(en)
|
1954-06-04 |
1957-03-27 |
Merck & Co Inc |
Derivatives of urea
|
|
ZA6706928B
(enExample)
|
1967-03-23 |
|
|
|
|
CH493195A
(de)
|
1968-01-23 |
1970-07-15 |
Ciba Geigy |
Schädlingsbekämpfungsmittel
|
|
GB1195672A
(en)
|
1968-02-01 |
1970-06-17 |
Mobil Oil Corp |
Novel Urea Derivatives and Herbicides containing the same
|
|
CH498859A
(de)
|
1968-07-17 |
1970-11-15 |
Agripat Sa |
Verfahren zur Herstellung von Thiadiazolyl-harnstoffen
|
|
GB1318291A
(en)
|
1970-04-15 |
1973-05-23 |
Shell Int Research |
Carboxamide derivatives and fungicidal compositions containing them
|
|
NL7106557A
(enExample)
|
1970-06-15 |
1971-12-17 |
|
|
|
IL72093A0
(en)
|
1983-06-20 |
1984-10-31 |
Lilly Co Eli |
N'-substituted(3-alkyl-5-isothiazolyl)urea derivatives
|
|
IE68593B1
(en)
|
1989-12-06 |
1996-06-26 |
Sanofi Sa |
Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US6579314B1
(en)
|
1995-03-10 |
2003-06-17 |
C.R. Bard, Inc. |
Covered stent with encapsulated ends
|
|
CA2247286A1
(en)
|
1996-02-26 |
1997-08-28 |
Hirohiko Hasegawa |
Sulfonylureidopyrazole derivatives
|
|
US6262096B1
(en)
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
EP0979823B1
(en)
|
1997-11-14 |
2006-03-29 |
Kowa Company Ltd. |
Novel amide compounds and drugs containing the same
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
|
CN1332726A
(zh)
|
1998-11-02 |
2002-01-23 |
卫福有限公司 |
吡咯烷化合物及其药物用途
|
|
JP2002539119A
(ja)
|
1999-03-08 |
2002-11-19 |
バイエル アクチェンゲゼルシャフト |
チアゾリルウレア誘導体および抗ウイルス剤としてのそれらの使用
|
|
CZ301366B6
(cs)
|
1999-03-29 |
2010-02-03 |
F. Hoffmann-La Roche Ag |
2-Fenyl-3-cykloalkylpropionamidová sloucenina, zpusob její prípravy a farmaceutický prostredek s jejím obsahem
|
|
US6610846B1
(en)
|
1999-03-29 |
2003-08-26 |
Hoffman-La Roche Inc. |
Heteroaromatic glucokinase activators
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
US6503949B1
(en)
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
JP2003503350A
(ja)
|
1999-06-30 |
2003-01-28 |
第一製薬株式会社 |
Ｖｌａ−４インヒビター化合物
|
|
US6806230B1
(en)
|
1999-09-09 |
2004-10-19 |
Kumiai Chemical Industry Co., Ltd. |
Pyrimidine derivatives and herbicides containing them
|
|
US6353111B1
(en)
|
1999-12-15 |
2002-03-05 |
Hoffmann-La Roche Inc. |
Trans olefinic glucokinase activators
|
|
WO2001057008A1
(en)
|
2000-02-07 |
2001-08-09 |
Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft |
2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
|
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
|
CA2407416C
(en)
|
2000-05-03 |
2006-07-18 |
Paige Erin Mahaney |
Alkynyl phenyl heteroaromatic glucokinase activators
|
|
AU5227001A
(en)
|
2000-05-03 |
2001-11-12 |
Hoffmann La Roche |
Hydantoin-containing glucokinase activators
|
|
EP1282611B1
(en)
|
2000-05-08 |
2004-10-20 |
F. Hoffmann-La Roche Ag |
Substituted phenylacetamides and their use as glucokinase activators
|
|
DK1283830T3
(da)
|
2000-05-08 |
2008-08-25 |
Hoffmann La Roche |
Para-amin-substituerede phenylamidglucokinase-aktivatorer
|
|
PT1305301E
(pt)
|
2000-07-20 |
2005-09-30 |
Hoffmann La Roche |
Benzeno-acetamidas alfa-acilo e alfa-heteroatomo-substituidas activadoras da glucocinase
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
WO2002046173A1
(en)
|
2000-12-06 |
2002-06-13 |
F. Hoffmann-La Roche Ag |
Fused heteroaromatic glucokinase activators
|
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
|
US6881746B2
(en)
|
2001-12-03 |
2005-04-19 |
Novo Nordick A/S |
Glucagon antagonists/inverse agonists
|
|
WO2003055482A1
(en)
|
2001-12-21 |
2003-07-10 |
Novo Nordisk A/S |
Amide derivatives as gk activators
|
|
AU2003243921B2
(en)
|
2002-06-27 |
2009-05-07 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
MXPA05009059A
(es)
|
2003-02-26 |
2005-10-19 |
Banyu Pharma Co Ltd |
Derivados de heteroarilcarbamoilbenceno.
|
|
US7111188B2
(en)
|
2003-07-31 |
2006-09-19 |
International Business Machines Corporation |
Dynamically configurable fault tolerance in autonomic computing with multiple service points
|
|
PT1723128E
(pt)
|
2004-01-06 |
2013-02-27 |
Novo Nordisk As |
Heteroaril-ureias e o seu uso como activadores da glicoquinase
|
|
US20070147220A1
(en)
|
2004-02-26 |
2007-06-28 |
Koninklijke Philips Electronics, N.V. |
Multiple-spiral hybrid disc for e-book applications
|
|
WO2005103050A2
(en)
|
2004-04-02 |
2005-11-03 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of rock and other protein kinases
|
|
JP2008502658A
(ja)
|
2004-06-17 |
2008-01-31 |
ノボ ノルディスク アクティーゼルスカブ |
肝臓選択的グルコキナーゼ活性化因子の使用
|
|
WO2006037233A1
(en)
|
2004-10-07 |
2006-04-13 |
Stem Cell Therapeutics Corp. |
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
US20060246141A1
(en)
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
US20100028439A1
(en)
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
JP2009500378A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー／エス |
グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
|
|
KR20080024211A
(ko)
|
2005-07-08 |
2008-03-17 |
노보 노르디스크 에이/에스 |
디시클로알킬 우레아 글루코키나제 활성제
|
|
BRPI0612996A2
(pt)
|
2005-07-14 |
2010-12-14 |
Novo Nordisk As |
ativadores de urÉia glucocinase
|
|
JP5419706B2
(ja)
|
2006-12-20 |
2014-02-19 |
タケダ カリフォルニア インコーポレイテッド |
グルコキナーゼアクチベーター
|
|
US8138185B2
(en)
|
2007-01-09 |
2012-03-20 |
Novo Nordisk A/S |
Urea glucokinase activators
|
|
AU2008204530B2
(en)
|
2007-01-11 |
2013-08-01 |
Vtv Therapeutics Llc |
Urea glucokinase activators
|
|
WO2009054251A1
(ja)
|
2007-10-25 |
2009-04-30 |
Sanyo Electric Co., Ltd. |
発電装置
|
|
EA018988B1
(ru)
|
2008-05-16 |
2013-12-30 |
Такеда Калифорния, Инк. |
Активаторы глюкокиназы
|
|
NZ603614A
(en)
|
2010-05-26 |
2014-10-31 |
Transtech Pharma Llc |
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
|
|
EP2392575A1
(en)
|
2010-06-04 |
2011-12-07 |
LEK Pharmaceuticals d.d. |
A novel synthetic approach to ß-aminobutyryl substituted compounds
|
|
CN118453592A
(zh)
|
2012-05-17 |
2024-08-09 |
Vtv治疗有限责任公司 |
用于治疗糖尿病的葡萄糖激酶活化剂组合物
|
|
AU2014226292B2
(en)
|
2013-03-04 |
2018-10-04 |
Vtv Therapeutics Llc |
Solid compositions comprising a glucokinase activator and methods of making and using the same
|
|
WO2014137797A2
(en)
|
2013-03-04 |
2014-09-12 |
Transtech Pharma, Llc |
Stable glucokinase activator compositions
|
|
JP6102611B2
(ja)
|
2013-07-31 |
2017-03-29 |
セイコーエプソン株式会社 |
液体噴射装置及びワイピング方法
|
|
CN109646404B
(zh)
|
2016-12-15 |
2022-10-04 |
华领医药技术（上海）有限公司 |
葡萄糖激酶激活剂的口服制剂及其制备方法
|
|
AU2019287437A1
(en)
|
2018-06-12 |
2020-09-10 |
Vtv Therapeutics Llc |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
|
WO2021167840A1
(en)
|
2020-02-18 |
2021-08-26 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
CN121202809A
(zh)
|
2020-06-08 |
2025-12-26 |
维特卫治疗有限责任公司 |
{2-[3-环己基-3-(反式-4-丙氧基-环己基)-脲基]-噻唑-5-基硫烷基}-乙酸的结晶形式及其用途
|
|
CN116194442A
(zh)
|
2020-06-08 |
2023-05-30 |
维特卫治疗有限责任公司 |
{2-[3-环己基-3-(反式-4-丙氧基-环己基)-脲基]-噻唑-5-基硫烷基}-乙酸的盐或共晶体及其用途
|